CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells - sprookjes - yvandenbroek - TriplyDB

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

http://www.wikidata.org/entity/Q36276395

about

Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1 CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs.Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1 CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism.Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism.Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells CD36: implications in cardiovascular disease Functional evolution of ADAMTS genes: evidence from analyses of phylogeny and gene organization Megakaryocytes, malignancy and bone marrow vascular niches Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management The BAI subfamily of adhesion GPCRs: synaptic regulation and beyond Crystal structure of the TSP-1 type 1 repeats Expression, purification and structural characterization of functionally replete thrombospondin-1 type 1 repeats in a bacterial expression system The metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways.Extracellular Matrix, a Hard Player in Angiogenesis Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by alpha3beta1 integrin and regulated by insulin-like growth factor-1 and CD98 Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity C-mannosylation and O-fucosylation of the thrombospondin type 1 module Expression of brain-specific angiogenesis inhibitor 2 (BAI2) in normal and ischemic brain: involvement of BAI2 in the ischemia-induced brain angiogenesis Neurovascular effects of CD47 signaling: promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1 Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism Lysosomal integral membrane protein II binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif Identification and characterization of abeta1,3-glucosyltransferase that synthesizes the Glc-beta1,3-Fuc disaccharide on thrombospondin type 1 repeats O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61)Determination of the CD148-Interacting Region in Thrombospondin-1 CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling The thrombospondin receptor CD47 (IAP) modulates and associates with alpha2 beta1 integrin in vascular smooth muscle cells Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1 CD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis Molecular basis of antiangiogenic thrombospondin-1 type 1 repeat domain interactions with CD36 Mechanistic exploration of phthalimide neovascular factor 1 using network analysis tools.

P2860

Q22253929-4FBF37A3-20A8-4B0B-84D8-47A6739098F8 Q24290677-1FF5339A-699D-460B-BC8C-5001C47E63DA Q24296427-C0492FA1-A4C3-4172-94CA-20743AB92A7B Q24302047-5593B220-90D9-4F1D-93BD-89BA2F0E4C58 Q24304430-0587CE37-201D-45E7-8A63-73C351A6F69B Q24316639-498BF91D-1E78-493D-8A9A-8F55C6E20BB2 Q24321591-FF71B5D0-7AF2-41A9-B376-879CAE61A0A1 Q24336644-E12BB998-EFCF-4251-98D7-6C44D7FCEE45 Q24521485-6B41A1EB-7511-466F-B8ED-35763ED55CCD Q24531386-CD2D8A31-7889-41E8-A8AC-CE4CDD353567 Q24535504-2F49ADFC-F2B1-4D87-AD68-4160E6DD960C Q24654057-994E5695-8457-4665-A4F3-E302BCB66F21 Q24678338-C2813805-BE0F-4D98-9589-F717E57658B4 Q24805033-42B8C3BD-DE3C-4463-BE85-0C23E37A2D7C Q26862087-9CAC8902-DBC1-413D-86B8-032DBF37558D Q26864499-7EE72296-5CCF-4956-8D44-640067AD8507 Q26864858-522C1AB4-B7F1-4C7E-BDEB-EDB72B10D81B Q27639866-1264E4F1-5D86-479B-BCAF-A04ABD8B2C98 Q27671576-FE0D3DDA-66E6-449E-88BD-C98441DCE468 Q27687896-15211751-D641-4549-9887-1EF88B4F0197 Q28072886-0A51CDCD-4D1E-4F52-8846-C91BB2497F77 Q28140972-1B295682-CF28-4F26-BC91-C5EB88550B39 Q28141127-C455D8FF-0B21-48AE-B10A-4FBC34020347 Q28143193-3DDCAFB2-1C7E-4A1B-A31D-9C43EB2698F6 Q28198140-A4F50B4B-6E50-4242-828D-7E0B53CB6E71 Q28240979-74C564D6-2FB4-4468-992A-24DF7B1F2B59 Q28251463-3C7C4F3D-3D6F-4A6B-B5C9-A4481AE058FA Q28256059-0CB2AE68-EA27-4E51-8866-85867403E200 Q28262922-56F98595-6946-40F6-B67D-982EEDE69CDA Q28267777-5AEFF2A6-6C81-4EAD-9B7C-B06131728085 Q28506312-92F5F10F-EE1D-4DBC-B439-DCAA1D2E9038 Q28513880-99465B16-5187-4A35-BFF6-BAD0847C8E81 Q28551843-797F9783-A62A-41E1-8CBE-40524190B413 Q28580132-89197CF7-8F78-41CD-8494-2D88485CBD21 Q28581719-43E435AF-903D-49A6-B079-B3F0455BFD1D Q28582206-0604AF4E-3E03-4E32-8D63-BA3611CEB137 Q28647132-0E3838CC-0C36-45AD-B29F-B11AEED29FB3 Q28729175-6B347DC1-96B1-4220-9371-320E4BC65467 Q29147397-21942C98-D695-4A69-808F-75549961C140 Q30431758-23B5E970-DAEB-4F6D-9002-B141584FE8C1

P2860

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

http://www.wikidata.org/entity/Q36276395

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

@ast

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

@en

type

label

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

@ast

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

@en

prefLabel

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

@ast

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

@en

P1433

Q36276395-E42EE6AC-E6C5-4EBC-B3DD-020EEF5FA334

P1476

Q36276395-696AA4F2-5846-4F7B-9FED-CFC3FC1E4B26

P2093

Q36276395-255858FA-2366-4C6C-85C6-FAFD753202E6

Q36276395-2CE52204-94E0-4B1C-AA9B-CA5A6232E3DB

Q36276395-558483B7-1F86-4437-AAC3-9AC5A7C73D06

Q36276395-71DD44C0-C201-4D54-B991-F929DD9D4151

Q36276395-ECD23604-AE83-45DA-B16D-E18120B4016D

Q36276395-F83671A2-BA8E-46DB-BBB6-C3014A54EAD7

P2860

Q36276395-01F2C34F-E848-4DED-BF0A-D93863AABFE9

Q36276395-04C5A725-6866-49FE-B9C3-B580A0612E9E

Q36276395-06DE596A-31DB-44BF-A834-319ECD6D742E

Q36276395-082CE9D7-C707-4CA0-8735-15CD5274BE51

Q36276395-0B610612-F0CA-4817-A834-21F70481C4F7

Q36276395-0F20A331-5B55-4D4A-A635-2905F9474CA6

Q36276395-10B816DB-A0B0-4CE3-A66D-44119F34FA97

Q36276395-11CA7E38-7D9E-4A1E-B31A-BB0CAB9348C8

Q36276395-1C9E9E1B-AB4D-40F8-B1A7-6874F384D16D

Q36276395-28CA58C9-2D50-4396-9EFB-325C4284BAF6

P304

Q36276395-AF922EFC-DCE3-4C5E-8930-AC0D981FE549

P31

Q36276395-658DD04E-2AA8-4E6E-9A99-9FE3A6F40E10

P356

Q36276395-CA3023CC-2F32-4886-9DBC-1DA47A4AC7CE

P407

Q36276395-EC93CF0A-A6C2-4CB3-B78D-BEA198F9E2FB

P433

Q36276395-90D96B46-37E3-4BDF-84F7-B9C33013427F

P478

Q36276395-895FA8A7-06F8-4013-9265-01BDF7E9233F

P577

Q36276395-E5E8642A-2D02-4B6C-8514-0A8B623277A8

P5875

Q36276395-E346CCB0-8F10-423C-B5D3-3712B53EF4FA

P698

Q36276395-326E3D1B-E224-4B75-810E-3009384B9D0D

P921

Q36276395-56740F2A-3F48-4B29-B5BE-8C87E470B7F3

P932

Q36276395-1EB22A91-2180-4B21-AA45-B72E11D4A804

P356

P1433

Journal of Cell Biology

P1476

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

@en

P2093

D W Dawson

http://www.w3.org/2001/XMLSchema#string

N P Bouck

http://www.w3.org/2001/XMLSchema#string

R L Silverstein

http://www.w3.org/2001/XMLSchema#string

R Zhong

http://www.w3.org/2001/XMLSchema#string

S F Pearce

http://www.w3.org/2001/XMLSchema#string

W A Frazier

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of the thrombospondin membrane receptor

Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets

Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1

Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion

Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin

Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells

Apoptosis by death factor

CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis

P304

707-717

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.138.3.707

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P577

1997-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277457352

http://www.w3.org/2001/XMLSchema#string

P698

9245797

http://www.w3.org/2001/XMLSchema#string

P921

P932

2141641

http://www.w3.org/2001/XMLSchema#string